Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3Sturge-Weber Syndrome 2Neoplasms 2Nausea 2Marijuana Abuse 2Colonic Neoplasms 2Anxiety Disorders 2Vomiting 1Solid Tumor 1Parasomnias 1Pain 1Glioblastoma 1Dysgeusia 1Drug Resistant Epilepsy 1Colorectal Neoplasms 1Cognitive Dysfunction 1Chemotherapy-Induced Peripheral Neuropathy 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Cachexia 1Breast Carcinoma In Situ 1Breast Cancer Female 1Arthralgia 1Appetitive Behavior 1

Interventions

nabiximols 3Medical Marijuana 3Cannabidiol 2Temozolomide 1Dronabinol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Marijuana Abuse × Cannabidiol × Clear all
NCT06518434 2024-07-24

CanHep

University Medical Center Groningen

Phase 2 Recruiting
20 enrolled
Gastrointestinal

Marijuana Abuse, Carcinoma, Hepatocellular

NCT04585841 2023-07-24

The Effect of Cannabidiol on Lean Body Mass in Patients Receiving Chemotherapy

University of Copenhagen

Phase 1 Completed
32 enrolled

Appetitive Behavior, Cachexia, Marijuana Abuse, Dysgeusia, Nausea, Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡